Differential diagnosis and psychopharmacology of dual disorders. (Q40815102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

review article

1 reference

title

Differential diagnosis and psychopharmacology of dual disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Decker KP

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Ries RK

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

Psychiatric Clinics of North America

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

703-718

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

The diagnosis and treatment of panic disorder in alcoholics: three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Psychiatric disorder, drinking and alcoholism: what are the links?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Alcohol use and abuse among diagnosed agoraphobics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Alcoholism, anxiety disorders, and agoraphobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Cocaine abuse among schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Psychiatric morbidity in adult inpatients with childhood histories of sexual and physical abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Self-medication among addicts with primary psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Alcohol abuse, substance abuse, and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Cigarette smoking and neuroleptic-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Antimuscarinic Agents as Substances of Abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Gilles de la Tourette's syndrome: effects of stimulant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Cocaine and Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Diagnostic and psychopharmacological treatment characteristics of 536 inpatients with posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Inner-city substance abuse patterns: a study of psychiatric inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Desipramine facilitation of initial cocaine abstinence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Alcoholism and panic disorder: is the comorbidity more than coincidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Relative Abuse Liability of Different Benzodiazepines in

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Carbamazepine for cocaine addiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Cocaine as a risk factor for acute dystonic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Psychopathology in hospitalized alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

First-rank symptoms as a diagnostic clue to multiple personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Pharmacological blocking agents for treating substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

The relation between alcohol problems and the anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Assessing the potential for buspirone dependence or abuse and effects of its withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Clinical features and management of intoxication due to hallucinogenic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Stimulant medications precipitate Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Acute neurologic and psychiatric complications associated with cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Cataleptic and anticataleptic effects of muscimol and gabaculine injected into globus pallidus and substantia nigra, and interactions with haloperidol or benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Acute dystonic reaction to cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Affective disorder and alcoholism in families of agoraphobics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

A family study of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Relationship between panic disorder and agoraphobia. A family study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Tardive dyskinesia in psychiatric patients with substance use disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Cocaine-associated multifocal tics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Cocaine, kindling, and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Benzodiazepine Withdrawal: Clinicians' Ratings of Carbamazepine Treatment Versus Traditional Taper Methods

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Carbamazepine treatment for benzodiazepine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Effectively treating stimulant-abusing schizophrenics: mission impossible?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Psychiatric diagnoses of treatment-seeking cocaine abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Psychopathology as a predictor of treatment outcome in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Benzodiazepine withdrawal: overview and implications for the treatment of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Substance abuse and schizophrenia: impediments to optimal care

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Cocaine-induced paranoia and psychosis proneness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

The clinical implications of primary diagnostic groups among alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Alcohol and drug interactions with antianxiety medications

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Histories of substance abuse in patients with postpsychotic depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Alcohol dependence and phobic anxiety states. I. A prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Comorbidity in mania at first hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Clinical phobias and avoidant personality disorder among alcoholics admitted to an alcoholism rehabilitation setting

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

Considerations in using psychotropic medication with dual diagnosis patients in recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930145-X

7 January 2021

10.1016/S0193-953X(18)30145-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8309808%20AND%20SRC:MED&resulttype=core&format=json